CEACAM5 and familial pancreatic carcinoma: Despite most research on CEA and its potential for predicting outcomes in pancreatic cancer involving only a small number of patients, a study by Lee et al. found that CEA could be a promising biomarker, particularly for those patients for whom surgery is not an option [27].